Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

976 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
Govier F, Potempa AJ, Kaufman J, Denne J, Kovalenko P, Ahuja S. Govier F, et al. Clin Ther. 2003 Nov;25(11):2709-23. doi: 10.1016/s0149-2918(03)80328-4. Clin Ther. 2003. PMID: 14693299 Clinical Trial.
Most patients had moderate ED (60.5%) of >or=1 year's duration (74.9%). Of 190 evaluable patients, 126 (66.3%) preferred to initiate treatment with tadalafil, compared with 64 (33.7%) with sildenafil (P < 0.001). ...
Most patients had moderate ED (60.5%) of >or=1 year's duration (74.9%). Of 190 evaluable patients, 126 (66.3%) preferred to initia …
Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S. Broderick GA, et al. J Sex Med. 2006 Jul;3(4):668-675. doi: 10.1111/j.1743-6109.2006.00273.x. J Sex Med. 2006. PMID: 16839323
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F, Wong DG, Ahuja S. Goldstein I, et al. J Sex Med. 2007 Jan;4(1):166-175. doi: 10.1111/j.1743-6109.2006.00402.x. J Sex Med. 2007. PMID: 17233782 Clinical Trial.
Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
Shabsigh R, Seftel AD, Rosen RC, Porst H, Ahuja S, Deeley MC, Garcia CS, Giuliano F. Shabsigh R, et al. Urology. 2006 Oct;68(4):689-96. doi: 10.1016/j.urology.2006.05.009. Urology. 2006. PMID: 17070333 Review. No abstract available.
Through the eyes of women: the partners' perspective on tadalafil.
Althof SE, Eid JF, Talley DR, Brock GB, Dunn ME, Tomlin ME, Natanegara F, Ahuja S. Althof SE, et al. Urology. 2006 Sep;68(3):631-5. doi: 10.1016/j.urology.2006.03.054. Epub 2006 Sep 18. Urology. 2006. PMID: 16979701 Clinical Trial.
CONCLUSIONS: Partners reported significantly improved overall sexual satisfaction and corroborated the man's report of improved erections and penetration ability with tadalafil 10 mg or 20 mg. ...
CONCLUSIONS: Partners reported significantly improved overall sexual satisfaction and corroborated the man's report of improved erect …
Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.
Morgentaler A, Barada J, Niederberger C, Donatucci C, Garcia CS, Natanegara F, Ahuja S, Wong DG. Morgentaler A, et al. J Sex Med. 2006 May;3(3):492-503. doi: 10.1111/j.1743-6109.2006.00209.x. J Sex Med. 2006. PMID: 16681475 Clinical Trial.
AIM: This U.S. multicenter open-label study used a noninferiority trial design to assess the efficacy of tadalafil 20 mg to treat erectile dysfunction (ED) in the black American and Hispanic groups compared with a reference group of Caucasians. ...
AIM: This U.S. multicenter open-label study used a noninferiority trial design to assess the efficacy of tadalafil 20 mg to treat ere …
The efficacy of tadalafil in clinical populations.
Lewis RW, Sadovsky R, Eardley I, O'Leary M, Seftel A, Wang WC, Shen W, Walker DJ, Wong DG, Ahuja S. Lewis RW, et al. J Sex Med. 2005 Jul;2(4):517-31. doi: 10.1111/j.1743-6109.2005.00068.x. J Sex Med. 2005. PMID: 16422847
Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS, Natanegara F, Ahuja S. Shabsigh R, et al. BJU Int. 2005 Oct;96(6):857-63. doi: 10.1111/j.1464-410X.2005.05750.x. BJU Int. 2005. PMID: 16153217
Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM Jr, Hague JA, Ahuja S. Young JM, et al. J Androl. 2005 May-Jun;26(3):310-8. doi: 10.2164/jandrol.04126. J Androl. 2005. PMID: 15866997 Clinical Trial.
Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.
Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L. Montorsi F, et al. J Urol. 2004 Sep;172(3):1036-41. doi: 10.1097/01.ju.0000136448.71773.2b. J Urol. 2004. PMID: 15311032 Clinical Trial.
976 results
Jump to page
Feedback